AB BIOMéRIEUX

AB bioMérieux is a privately held company that designs, develops, produces, and markets diagnosis systems for medical applications.

#SimilarOrganizations #More

AB BIOMéRIEUX

Industry:
Health Care Health Diagnostics

Founded:
1967-01-01

Address:
Askim, Vastra Gotaland, Sweden

Country:
Sweden

Status:
Active

Contact:
46 31 68 84 90


Similar Organizations

alma-medical-imaging-logo

Alma Medical Imaging

Alma Medical Imaging is a software company that develops new diagnostics products for surgical planning.

amplex-diagnostics-logo

Amplex Diagnostics

Amplex Diagnostics is a privately held company for the development, production and distribution of In Vitro Diagnostics.

not_available_image

Teraklin

Teraklin is a privately held company that develops artificial organ support products.

More informations about "AB bioMérieux"

Who we are | Pioneering Diagnostics - bioMérieux Website

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an …See details»

Our Company - bioMérieux

In 2013, bioMérieux celebrated a major milestone, our 50th anniversary. Our development during these years has been driven by a pioneering spirit and unrelenting commitment to improve …See details»

bioMérieux at a glance | Pioneering Diagnostics

Beginning with Marcel Mérieux’s development of the first anti-tetanus serum over a century ago, innovation has always been at the heart of bioMérieux. This pioneering spirit continues to drive our R&D teams that combine their state-of …See details»

AB bioMérieux - Crunchbase Company Profile & Funding

Organization. AB bioMérieux . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. AB bioMérieux is a privately held company that designs, …See details»

bioMérieux | Pioneering Diagnostics

BioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2024: Consolidated sales amounted to €2,871 million, …See details»

bioMérieux - Wikipedia

BioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l'Étoile, France, close to Lyon.bioMérieux is present in 44 countries and serves more …See details»

bioMérieux Canada

BioMérieux has chosen to focus on the diagnosis of infectious diseases and high medical value tests for cancer and cardiovascular diseases. For several years, governments support the …See details»

About us | bioMérieux - biomerieux.ca

BioMérieux Worldwide. About Us. We are a company with an entrepreneurial spirit with a passion for innovation. We understand your challenges and imagine not only products and services to …See details»

bioMérieux - LinkedIn

BioMérieux | 316,765 followers on LinkedIn. Pioneering Diagnostics | Pioneering Diagnostics A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 …See details»

Home | Pioneering Diagnostics - bioMérieux …

BioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2024: Consolidated sales amounted to €2,871 million, representing an organic growth of +10.3% …See details»

AB bioMérieux - PitchBook

AB bioMérieux General Information Description. Producer of diagnostics products. The company's product line, Etest®, is used to determine the exact Minimum Inhibitory Concentration (MIC) of …See details»

Our History - bioMérieux

Our History. bioMérieux’s commitment to public health and expertise in biology are rooted in its unique family history.In 1897, Marcel Mérieux, a student of Louis Pasteur, founded an analysis …See details»

bioMérieux Increases its Lead in Microbiology with the …

Jun 18, 2008 bioMérieux, a world leader in the field of in vitro diagnostics has concluded an agreement to acquire the privately held AB BIODISK, a Swedish in vitro diagnostics company …See details»

HIV ASSAYS: OPERATIONAL CHARACTERISTICS

• Vironostika® HIV Uni-Form II Ag/Ab (bioMérieux bv) Section 2 of this report provides background information on the series. Sections 3 and ... In 1988, the World Health …See details»

2021 ANNUAL REPORT - bioMérieux

Biomérieux headquarters in marcy-l’Étoile (france). summary 2 our company purpose 3 edito 4 business model 6 key figures 8 life of our sites 10 the value of diagnostics 12 public health 22 …See details»

Notre Entreprise - bioMérieux Canada

En 2013, bioMérieux a fêté une étape importante : son 50ème anniversaire! Notre développement durant ces années a été inspiré par notre esprit pionnier et notre continuel engagement pour …See details»

Oxford Biomedica and Institut Mérieux Enter into Exclusive …

Sep 20, 2023 Oxford Biomedica and Institut Mérieux enter into exclusive negotiations with respect to the proposed acquisition by Oxford Biomedica of ABL Europe from Institut Mérieux …See details»

Oxford Biomedica signs agreement to acquire ABL Europe …

Dec 4, 2023 – Oxford Biomedica announces the signing of a sale and purchase agreement with Institut Mérieux for the acquisition of ABL Europe – The transaction: Provides Oxford …See details»

| bioMérieux

Une fois de plus, bioMérieux et Emerging and Pandemic Infections Consortium (EPIC) s'associent pour organiser la deuxième édition du symposium annuel sur la résistance aux antimicrobiens …See details»

bioMérieux Canada | Pioneering Diagnostics

Dec 23, 2014 bioMérieux provides in vitro diagnostic solutions (reagents, instruments, software, services) that determine the source of disease and contamination to improve patient health …See details»

linkstock.net © 2022. All rights reserved